drugset / Trial / NCT02594410

Zainidip in Renal Artery Stenosis

NCT02594410

Phase 4 Completed 149 enrolled Lee's Pharmaceutical Limited
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of renal artery stent combined with standardized medical therapy as treatment for renal artery stenosis.

Timeline

Start
2011-09
Primary completion
2014-03
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Background Aspirine Unknown 100 mg
Background Clopidogrel Small molecule 75 mg
Background Lercanidipine Small molecule 10 mg
Background Lercanidipine Small molecule 20 mg

Indications